ストックスクリーナーアプリを入手
0.394
0.13%
-0.0005
前日終値:
$0.3945
開ける：
$0.389
24時間の取引高:
664.38K
Relative Volume:
0.08
時価総額：
$8.52M
収益：
-
当期純損益:
$-6.07M
株価収益率:
-0.0682
EPS:
-5.78
ネットキャッシュフロー:
$-7.34M
1週間 パフォーマンス:
+3.71%
1か月 パフォーマンス:
+7.07%
6か月 パフォーマンス:
-46.84%
1年 パフォーマンス:
-59.34%
1日の値動き範囲:
$0.3815
$0.4099
1週間の範囲:
$0.3487
$0.4156
52週間の値動き範囲:
$0.22
$1.30
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
名前
Adial Pharmaceuticals Inc
セクター
電話
434-422-9800
住所
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
ADIL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
0.394 | 8.53M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-14 | 開始されました | Rodman & Renshaw | Buy |
| 2018-10-30 | 開始されました | Maxim Group | Buy |
| 2018-10-11 | 開始されました | Dawson James | Buy |
Adial Pharmaceuticals Inc (ADIL) 最新ニュース
Can Adial Pharmaceuticals Inc. Bounce Back From Weekly Low2025 Performance Recap & Weekly Chart Analysis and Trade Guides - sundaytimes.kr
Adial Pharmaceuticals Q2 Earnings: Net Loss Down to $2M - AInvest
Adial Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update - TradingView
Adial's Genetic-Targeted Alcohol Treatment Heads to Phase 3 After FDA Green Light - Stock Titan
Adial Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Adial Pharmaceuticals files to register resale of 6.7M shares from warrant conversions - MSN
Adial Pharmaceuticals Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView
Adial Pharmaceuticals Completes FDA Meeting, Advances AD04 into Phase 3 Clinical Development - AInvest
Adial Pharmaceuticals' Regulatory and Strategic Momentum with AD04: A Catalyst for Partnership and Growth in a High-Potential Market - AInvest
Adial Pharmaceuticals completes FDA meeting for alcohol disorder drug By Investing.com - Investing.com South Africa
Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting | AD - GuruFocus
Adial Pharmaceuticals completes FDA meeting for alcohol disorder drug - Investing.com
Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting - GlobeNewswire
Adial Pharmaceuticals Completes Successful FDA Meeting for Phase 3 Trial of AD04 for Alcohol Use Disorder Treatment. - AInvest
Adial's Alcohol Addiction Treatment Gets FDA Green Light for Pivotal Phase 3 Trial, Partnership Talks Heat Up - Stock Titan
Candlestick Reversal Detected on Adial Pharmaceuticals Inc.’s ChartProfit Focused Trade Alerts - beatles.ru
Sentiment Tools Show Shift in Trader Mood on Adial Pharmaceuticals Inc.Weekly Stock Opportunity Radar Scanner Activated - beatles.ru
Technical Bounce Expected in Adial Pharmaceuticals Inc. Next WeekSector Based Breakout Stock Forecast Issued - metal.it
Published on: 2025-08-04 18:30:20 - beatles.ru
Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket - Benzinga
What is the risk reward ratio of investing in Adial Pharmaceuticals Inc. stockBuild wealth with reliable stock picks - Jammu Links News
How many analysts rate Adial Pharmaceuticals Inc. as a “Buy”Rapid growth opportunities - Jammu Links News
What drives Adial Pharmaceuticals Inc. stock priceTriple returns potential - Jammu Links News
How does Adial Pharmaceuticals Inc. generate profit in a changing economyBoost your returns with professional guidance - Jammu Links News
What analysts say about Adial Pharmaceuticals Inc. stockHigh-profit capital plays - Jammu Links News
How strong is Adial Pharmaceuticals Inc. company’s balance sheetFree Stock Selection - Jammu Links News
Adial Pharmaceuticals Approves Share Increase Amid Ongoing Financial Struggles - AInvest
What is Adial Pharmaceuticals Inc. company’s growth strategyGet timely alerts on market opportunities - Jammu Links News
What is the dividend policy of Adial Pharmaceuticals Inc. stockGet exclusive market analysis for investors - Jammu Links News
What are Adial Pharmaceuticals Inc. company’s key revenue driversMaximize returns with disciplined trading approaches - Jammu Links News
What catalysts could drive Adial Pharmaceuticals Inc. stock higher in 2025Dynamic growth stocks - Jammu Links News
Published on: 2025-08-03 01:06:20 - jammulinksnews.com
Is Adial Pharmaceuticals Inc. a growth stock or a value stockBreakout Stocks Tracker With High Returns - jammulinksnews.com
Adial Pharmaceuticals shareholders approve share increases and board proposals By Investing.com - Investing.com Australia
Adial Pharmaceuticals Enters New Sales Agreement - TipRanks
Adial Pharmaceuticals shareholders approve share increases and board proposals - Investing.com
Adial Pharmaceuticals Approves Share Increase at Annual Meeting - TipRanks
Adial Pharmaceuticals Inc. Plunges 10.55% Amid Investor Concerns - AInvest
SHEN files 8-K, releases Q2 2025 earnings press release | ADIL SEC FilingForm 424B5 - Stock Titan
What are the technical indicators suggesting about Adial Pharmaceuticals Inc.Chart Pattern Planner For Beginners - Jammu Links News
Adial Pharmaceuticals Inc. Plunges 16.67% in Pre-Market Trading - AInvest
Adial Pharmaceuticals Inc. Shows Risk Reward Favoring UpsideBuy Signal Based on Chart Analysis Confirmed - metal.it
Alcohol Use Disorder Pipeline 2025: Therapies Under - openPR.com
Adial Pharmaceuticals Inc (ADIL) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):